BRIVATOP
NeuropsychiatryBrivaracetam is a third-generation antiepileptic racetam derivative and a 4-n-propyl analogue of levetiracetam. It is used in the treatment of partial-onset seizures. Brivaracetam binds SV2A with 20 time’s higher affinity than levetiracetam. SV2A is known to play a role in epileptogenesis through modulation of synaptic GABA release. It is thought that brivaracetam exerts its anti-epileptogenic…
Know More